Show simple item record

Authordc.contributor.authorMaia, Hugo 
Authordc.contributor.authorAlbernaz, Marco Aurelio es_CL
Authordc.contributor.authorBaracat, Edmund Chada es_CL
Authordc.contributor.authorBarbosa, Ione Cristina es_CL
Authordc.contributor.authorBossemeyer, Ronald es_CL
Authordc.contributor.authorHernández Bueno, Alberto es_CL
Authordc.contributor.authorGonzález Campos, Óscar es_CL
Authordc.contributor.authorCarranza Lira, Sebastián es_CL
Authordc.contributor.authorFigueroa Casas, Pedro es_CL
Authordc.contributor.authorMonterrosa Castro, Alvaro es_CL
Authordc.contributor.authorRodrigues de Lima, Geraldo es_CL
Authordc.contributor.authorMelo, Nilson R. de es_CL
Authordc.contributor.authorFernandes, César Eduardo es_CL
Authordc.contributor.authorSantos González, Javier es_CL
Authordc.contributor.authorEspinosa Larrañaga, Francisco es_CL
Authordc.contributor.authorSiseles, Néstor es_CL
Authordc.contributor.authorMurillo Uribe, Alfonso es_CL
Authordc.contributor.authorMolina Vilchez, Rafael es_CL
Admission datedc.date.accessioned2009-05-07T16:31:40Z
Available datedc.date.available2009-05-07T16:31:40Z
Publication datedc.date.issued2006-08-20
Cita de ítemdc.identifier.citationMATURITAS Volume: 55 Issue: 1 Pages: 5-13 Published: AUG 20 2006en
Identifierdc.identifier.issn0378-5122
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/127812
Abstractdc.description.abstractObjective: Data from placebo-controlled, randomized clinical trials conducted during the past few years resulted in critical re-evaluation of the overall health benefits of hormone therapy (HT) in women during the menopausal transition and thereafter. These data stimulated vigorous debate among experts and produced several position papers by North American and European authorities providing guidance on the use of HT. It is well known that cultural, geographic and ethnic differences influence the acceptance and risk perception of HT. Therefore, it was considered essential to present a position specifically relevant to Latin American countries. Methods: A Latin American Expert Panel, convening in Salvador, Bahia, Brazil, obtained consensus on re commendations for HT that incorporated the findings of the most recently published reports. The panelists' opinions were surveyed by means of the Likert scale along five categories ranging from complete agreement to complete disagreement. Results: The Panel presented 13 recommendations and considered three additional issues relevant to HT use. There was consensus that HT during the perimenopause and thereafter is warranted in Latin American women in particular for the management of vasomotor symptoms. HT may also be an option for osteoporosis prevention in women at significant risk, after evaluation of risks/benefits and after consideration of alternative therapies. HT should be individualized and prescribed at the lowest effective dose. Conclusions: The Panel concluded that HT remains a safe and effective treatment option for peri- and postmenopausal Latin American women.en
Lenguagedc.language.isoenen
Publisherdc.publisherELSEVIERen
Keywordsdc.subjectESTROGEN PLUS PROGESTINen
Títulodc.titleLatin American position on the current status of hormone therapy during the menopausal transition and thereafteren
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record